1. Home
  2. PIII vs CCEL Comparison

PIII vs CCEL Comparison

Compare PIII & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo P3 Health Partners Inc.

PIII

P3 Health Partners Inc.

N/A

Current Price

$5.50

Market Cap

33.8M

Sector

Health Care

ML Signal

N/A

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

N/A

Current Price

$3.89

Market Cap

32.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PIII
CCEL
Founded
2015
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Managed Health Care
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.8M
32.7M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
PIII
CCEL
Price
$5.50
$3.89
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $18.00
N/A
AVG Volume (30 Days)
11.0K
★ 13.0K
Earning Date
11-12-2026
07-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.07
Revenue
★ $1,459,080,000.00
$25,384,279.00
Revenue This Year
$6.32
N/A
Revenue Next Year
$9.37
N/A
P/E Ratio
★ N/A
$59.57
Revenue Growth
N/A
★ 9.76
52 Week Low
$1.52
$2.72
52 Week High
$16.89
$4.90

Technical Indicators

Market Signals
Indicator
PIII
CCEL
Relative Strength Index (RSI) 18.00 58.37
Support Level $2.39 $3.10
Resistance Level $11.55 $4.71
Average True Range (ATR) 0.35 0.30
MACD -0.10 0.01
Stochastic Oscillator 0.00 80.77

Price Performance

Historical Comparison
PIII
CCEL

About PIII P3 Health Partners Inc.

P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: